[1]
|
Morikawa, M., Derynck, R. and Miyazono, K. (2016) TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology. Cold Spring Harbor Perspectives in Biology, 8, a021873.
https://doi.org/10.1101/cshperspect.a021873
|
[2]
|
Ghazaly, M., Abu, F.N., Raafat, D.M., Mohammed, N.A. and Nadel, S. (2021) Acute Viral Bronchiolitis as a Cause of Pediatric Acute Respiratory Distress Syndrome. European Journal of Pediatrics, 180, 1229-1234.
https://doi.org/10.1007/s00431-020-03852-9
|
[3]
|
Li, Y., Wang, X., Blau, D.M., et al. (2022) Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Children Younger than 5 Years in 2019: A Systematic Analysis. Lancet, 399, 2047-2064. https://doi.org/10.1016/S0140-6736(22)00478-0
|
[4]
|
Lee, C.Y., Sung, C.H., Wu, M.C., et al. (2023) Clinical Characteristics and Differential Cytokine Expression in Hospitalized Taiwanese Children with Respiratory Syncytial Vi-rus and Rhinovirus Bronchiolitis. Journal of Microbiology, Immunology and Infection, 56, 282-291. https://doi.org/10.1016/j.jmii.2022.08.013
|
[5]
|
Sigurs, N., Bjarnason, R., Sigurbergsson, F., Kjellman, B. and Björkstén, B. (1995) Asthma and Immunoglobulin E Antibodies after Respiratory Syncytial Virus Bronchiolitis: A Pro-spective Cohort Study with Matched Controls. Pediatrics, 95, 500-505. https://doi.org/10.1542/peds.95.4.500
|
[6]
|
Folkerts, G., Walzl, G. and Openshaw, P.J. (2000) Do Common Childhood Infections ‘Teach’ the Immune System Not to Be Allergic? Trends in Immunology, 21, 118-120. https://doi.org/10.1016/S0167-5699(00)01582-6
|
[7]
|
Sigurs, N., Bjarnason, R., Sigurbergsson, F. and Kjellman, B. (2000) Respiratory Syncytial Virus Bronchiolitis in Infancy Is an Important Risk Factor for Asthma and Allergy at Age 7. American Journal of Respiratory and Critical Care Medicine, 161, 1501-1507. https://doi.org/10.1164/ajrccm.161.5.9906076
|
[8]
|
Walker, C.L.F., Rudan, I., Liu, L., et al. (2013) Global Burden of Childhood Pneumonia and Diarrhoea. The Lancet, 381, 1405-1416. https://doi.org/10.1016/S0140-6736(13)60222-6
|
[9]
|
林立, 李昌崇. 呼吸道合胞病毒感染发病机制[J]. 中华儿科杂志, 2006, 44(9): 673-675.
|
[10]
|
Piedimonte, G. and Perez, M.K. (2014) Respiratory Syncytial Virus Infection and Bronchiolitis. Pediatrics in Review, 35, 519-530. https://doi.org/10.1542/pir.35.12.519
|
[11]
|
Tregoning, J.S. and Schwarze, J. (2010) Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology. Clinical Microbiology Reviews, 23, 74-98. https://doi.org/10.1128/CMR.00032-09
|
[12]
|
Eisenhut, M. (2006) Ex-trapulmonary Manifestations of Severe Respiratory Syncytial Virus Infection—A Systematic Review. Critical Care, 10, Article No. R107. https://doi.org/10.1186/cc4984
|
[13]
|
Kenmoe, S., Atenguena, O.E., Takuissu, G.R., et al. (2022) Association between Early Viral Lower Respiratory Tract Infections and Subsequent Asthma Development. World Journal of Critical Care Medicine, 11, 298-310.
https://doi.org/10.5492/wjccm.v11.i4.298
|
[14]
|
Coutts, J., Fullarton, J., Morris, C., et al. (2020) Association be-tween Respiratory Syncytial Virus Hospitalization in Infancy and Childhood Asthma. Pediatric Pulmonology, 55, 1104-1110. https://doi.org/10.1002/ppul.24676
|
[15]
|
Be’er, M., Bushmitz, S., Cahal, M., et al. (2022) Asthma Risk after a Pediatric Intensive Care Unit Admission for Respiratory Syncytial Virus Bronchiolitis. Pediatric Pulmonology, 57, 1677-1683. https://doi.org/10.1002/ppul.25953
|
[16]
|
Baraldi, E., Checcucci, L.G., Costantino, C., et al. (2022) RSV Disease in Infants and Young Children: Can We See a Brighter Future? Human Vaccines & Immunotherapeutics, 18, Article ID: 2079322.
https://doi.org/10.1080/21645515.2022.2079322
|
[17]
|
Ball, T.M., Castro-Rodriguez, J.A., Griffith, K.A., et al. (2000) Siblings, Day-Care Attendance, and the Risk of Asthma and Wheezing during Childhood. The New England Journal of Medicine, 343, 538-543.
https://doi.org/10.1056/NEJM200008243430803
|
[18]
|
Scheltema, N.M., Gentile, A., Lucion, F., et al. (2017) Global Respiratory Syncytial Virus-Associated Mortality in Young Children (RSV GOLD): A Retrospective Case Series. The Lancet Global Health, 5, e984-e991.
https://doi.org/10.26226/morressier.5ad774e1d462b80296ca6e1d
|
[19]
|
Packnett, E.R., Winer, I.H., Oladapo, A. and Wojdyla, M. (2023) Risk of RSV-Related Hospitalization Is Associated with Gestational Age in Preterm (Born at 29-34 wGA) Infants without Outpatient Palivizumab Administration. Human Vaccines & Immunotherapeutics, 19, Article ID: 2252289. https://doi.org/10.1080/21645515.2023.2252289
|
[20]
|
Azzari, C., Baraldi, E., Bonanni, P., et al. (2021) Epidemiology and Prevention of Respiratory Syncytial Virus Infections in Children in Italy. Italian Journal of Pediatrics, 47, Article No. 198.
https://doi.org/10.1186/s13052-021-01148-8
|
[21]
|
Checchia, P. (2008) Identification and Management of Severe Respiratory Syncytial Virus. American Journal of Health-System Pharmacy, 65, S7-S12. https://doi.org/10.2146/ajhp080439
|
[22]
|
Weisman, L. (2003) Populations at Risk for Developing Respiratory Syn-cytial Virus and Risk Factors for Respiratory Syncytial Virus Severity: Infants with Predisposing Conditions. The Pedi-atric Infectious Disease Journal, 22, S33-S39.
https://doi.org/10.1097/01.inf.0000053883.08663.e5
|
[23]
|
Welliver, R.C. (2003) Review of Epidemiology and Clinical Risk Factors for Severe Respiratory Syncytial Virus (RSV) Infection. The Journal of Pediatrics, 143, S112-S117. https://doi.org/10.1067/S0022-3476(03)00508-0
|
[24]
|
Dixon, D.L. (2015) The Role of Human Milk Immunomodulators in Protecting against Viral Bronchiolitis and Development of Chronic Wheezing Illness. Children, 2, 289-304. https://doi.org/10.3390/children2030289
|
[25]
|
Demers-Mathieu, V., Lueangsakulthai, J., Qu, Y., et al. (2020) Binding and Neutralizing Capacity of Respiratory Syncytial Virus (RSV)-Specific Recombinant IgG Against RSV in Human Milk, Gastric and Intestinal Fluids from Infants. Nutrients, 12, Article 1904. https://doi.org/10.3390/nu12071904
|
[26]
|
Drysdale, S.B., Green, C.A. and Sande, C.J. (2016) Best Practice in the Prevention and Management of Paediatric Respiratory Syncytial Virus Infection. Therapeutic Advances in Infectious Disease, 3, 63-71.
https://doi.org/10.1177/2049936116630243
|
[27]
|
刘文宽. 广州儿童呼吸道病原体流行与气候相关性及呼吸道合胞病毒诊断技术研究[D]: [博士学位论文]. 广州: 广州医科大学, 2017.
|
[28]
|
傅生芳, 王云瑾, 朱传凤, 等. 呼吸道合胞病毒TaqMan(R)实时定量RT-PCR检测方法的建立[J]. 中国生物制品学杂志, 2018, 31(11): 1257-1261, 1267.
|
[29]
|
Somerville, L.K., Ratnamohan, V.M., Dwyer, D.E., et al. (2015) Molecular Diagnosis of Respiratory Virus-es. Pathology, 47, 243-249. https://doi.org/10.1097/PAT.0000000000000240
|
[30]
|
Baraldi, E., Lanari, M., Manzoni, P., et al. (2014) Inter-Society Consensus Document on Treatment and Prevention of Bronchiolitis in Newborns and In-fants. Italian Journal of Pediatrics, 40, Article No. 65.
https://doi.org/10.1186/1824-7288-40-65
|
[31]
|
董琳, 李海燕. 呼吸道合胞病毒感染治疗的研究进展[J]. 中华妇幼临床医学杂志(电子版), 2014, 10(4): 444-447.
|
[32]
|
Ventre, K. and Randolph, A.G. (2007) Ribavirin for Respira-tory Syncytial Virus Infection of the Lower Respiratory Tract in Infants and Young Children. Cochrane Database of Systematic Reviews, 24, CD000181.
https://doi.org/10.1002/14651858.CD000181.pub3
|
[33]
|
De Clercq, E. (2015) Chemotherapy of Respiratory Syn-cytial Virus Infections: The Final Breakthrough. International Journal of Antimicrobial Agents, 45, 234-237. https://doi.org/10.1016/j.ijantimicag.2014.12.025
|
[34]
|
徐烔烔, 吴安娜, 倪舒芹. 重组人干扰素治疗儿童呼吸道合胞病毒感染的临床疗效[J]. 中华医院感染学杂志, 2019, 29(18): 2861-2864, 2868.
|
[35]
|
国家呼吸系统疾病临床医学研究中心, 中华医学会儿科学分会呼吸学组, 中国医师协会呼吸医师分会儿科呼吸工作委员会, 等. 儿童呼吸道合胞病毒感染诊断、治疗和预防专家共识[J]. 中华实用儿科临床杂志, 2020, 35(4): 241-250. https://doi.org/10.3760/cma.j.cn101070-20200225-00243
|
[36]
|
Kuzik, B.A., Al-Qadhi, S.A., Kent, S., et al. (2007) Nebulized Hypertonic Saline in the Treatment of Viral Bronchiolitis in Infants. The Journal of Pediatrics, 151, 266-270, 270-271. https://doi.org/10.1016/j.jpeds.2007.04.010
|
[37]
|
Mandelberg, A. and Amirav, I. (2010) Hypertonic Saline or High Volume Normal Saline for Viral Bronchiolitis: Mechanisms and Rationale. Pediatric Pulmonology, 45, 36-40. https://doi.org/10.1002/ppul.21185
|
[38]
|
Na’Amnih, W., Kassem, E., Tannous, S., et al. (2022) Incidence and Risk Factors of Hospitalisations for Respiratory Syncytial Virus among Children Aged Less than 2 Years. Epidemiology & Infection, 150, e45.
https://doi.org/10.1017/S0950268822000152
|
[39]
|
Mazur, N.I., Higgins, D., Nunes, M.C., et al. (2018) The Res-piratory Syncytial Virus Vaccine Landscape: Lessons from the Graveyard and Promising Candidates. The Lancet Infec-tious Diseases, 18, e295-e311.
https://doi.org/10.1016/S1473-3099(18)30292-5
|
[40]
|
Luna, M.S., Manzoni, P., Paes, B., et al. (2020) Expert Consensus on Palivizumab Use for Respiratory Syncytial Virus in Developed Countries. Paediatric Respiratory Reviews, 33, 35-44. https://doi.org/10.1016/j.prrv.2018.12.001
|
[41]
|
Garegnani, L., Styrmisdottir, L., Roson, R.P., et al. (2021) Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Children. Cochrane Database of Systematic Reviews, 11, CD013757.
https://doi.org/10.1002/14651858.CD013757.pub2
|